What question did this study set out to answer?

The aim is to explore how amarogentin (AG) alleviates cholestatic liver injury induced by ANIT.

February 8, 20260 citations

Amarogentin relieves cholestatic liver injury caused by ANIT in rats by regulating the FXR and Nrf2 pathways.

WWWenxiang WangOil Crops Research Institute WXWei XiongChongqing Three Gorges University JMJingxin MaoSouthwest University

Key Points

The aim is to explore how amarogentin (AG) alleviates cholestatic liver injury induced by ANIT.
Administered amarogentin to rats with ANIT-induced liver injury.
Measured bile flow rates and liver function markers.
Assessed liver histology for structural changes.
Analyzed the activation of Nrf2 and PI3K/Akt signaling pathways.
Amarogentin improved bile flow rates significantly.
Reduced liver function marker levels and serum enzyme concentrations.
Enhanced histological appearance of the liver.
Activated Nrf2 signaling through the PI3K/Akt pathway.

Abstract

This study demonstrated that AG may mitigate ANIT-induced cholestatic liver damage by improving the bile flow rates, decreasing the concentrations of liver function markers and serum enzyme levels, enhancing liver histology, activating Nrf2 via the PI3K/Akt signaling pathway, and controlling bile acid transport.

Perguntar à IA

Bookmark

View Full Paper